Sign In
Buy ACB
$2.79
-0.0400 (-1.41%)
At Close: Jul 31, 2026
Aurora Completes First-Ever EU-GMP Certification for the Company's Dedicated Distribution Centre
07:00am, Monday, 14'th Jul 2025
Adding a fourth certified facility within its global network increases operational capacity to better serve international medical markets NASDAQ | TSX: ACB EDMONTON, AB , July 14, 2025 /PRNewswire/
Aurora Cannabis Inc. (ACB) Announces Filing and Mailing of the Management Information
10:55am, Wednesday, 09'th Jul 2025
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, is pleased to announce that the management information circul
Your vote is important no matter how many shares you own. Please vote today.
Americans Should Buy Canadian Cannabis Companies
07:30am, Saturday, 05'th Jul 2025
Canadian LPs offer compelling risk/reward versus U.S. cannabis stocks, with stronger balance sheets, tangible book value, and global opportunities due to federal legality. Despite recent rallies, Cana
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc. - ACB
10:00am, Wednesday, 02'nd Jul 2025
NEW YORK , July 2, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. ("Aurora Cannabis" or the "Company") (NASDAQ: ACB). Such investors are
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc. - ACB
05:10pm, Friday, 27'th Jun 2025
NEW YORK , June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. ("Aurora Cannabis" or the "Company") (NASDAQ: ACB). Such investors are adv
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc. - ACB
10:00am, Friday, 27'th Jun 2025
NEW YORK , June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. ("Aurora Cannabis" or the "Company") (NASDAQ: ACB). Such investors ar
Aurora Expands Patient Access to Medical Cannabis in Canada with Extended Compassionate Pricing Program
07:00am, Thursday, 26'th Jun 2025
Canada's Largest Medical Cannabis Company Offers the Country's Most Inclusive Medical Cannabis Pricing Program NASDAQ | TSX: ACB EDMONTON, AB , June 26, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASD
Aurora Sets New Standard in Poland with the Launch of Two High Potency Flower Products
07:00am, Tuesday, 24'th Jun 2025
Proprietary Genetics to be the Highest Potency Medical Cannabis Products Available on the Market NASDAQ | TSX: ACB EDMONTON, AB , June 24, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:
Aurora Cannabis Falls On Weak 2026 Outlook Despite Record Q4 Revenues
09:00am, Sunday, 22'nd Jun 2025
Aurora Cannabis recently reported improved Q4-2025 results. ACB's international medical cannabis sales are increasing revenues. The company reported record revenues, but low gross profit and weak 2026
3 Cannabis Stocks For Investors To Secure For Future Gains
12:12pm, Friday, 20'th Jun 2025
The current state of the cannabis sector has people feeling a type of way. To be more descriptive, those who are invested in marijuana stocks are feeling the backlash of the market. For some time, the
Aurora Cannabis Advises of Second False Article from Investing.com
07:39am, Thursday, 19'th Jun 2025
NASDAQ | TSX: ACB EDMONTON, AB , June 19, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has bec
Aurora Cannabis Denies News of Acquisition of MedLeaf Therapeutics
04:34pm, Wednesday, 18'th Jun 2025
NASDAQ | TSX: ACB EDMONTON, AB , June 18, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has be
Aurora Cannabis: Poland Headwinds Result In Disappointing Outlook (Rating Downgrade)
03:20pm, Wednesday, 18'th Jun 2025
Aurora Cannabis reported mixed Q4/FY2025 results, with higher-than-expected revenues offset by lower profitability due to a number of one-time expenses. Following substantial growth in recent quarters
Aurora Cannabis Inc. (ACB) Q4 2025 Earnings Call Transcript
10:43am, Wednesday, 18'th Jun 2025
Aurora Cannabis Inc. (NASDAQ:ACB ) Q4 2025 Earnings Conference Call June 18, 2025 8:00 AM ET Company Participants Kevin Niland - Corporate Participant Miguel Martin - CEO & Executive Chairman Simona K
